CNSP logo

CNS Pharmaceuticals (CNSP) Company Overview

Profile

Full Name:

CNS Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

November 8, 2019

Indexes:

Not included

Description:

CNS Pharmaceuticals is a biotechnology company focused on developing innovative treatments for brain cancer. They aim to improve patient outcomes through advanced therapies, particularly targeting glioblastoma, a challenging type of brain tumor. Their research emphasizes safety and effectiveness in addressing critical medical needs.

Events Calendar

Earnings

Next earnings date:

Apr 1, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

Apr 1, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Feb 21, 2025

Analyst ratings

Recent major analysts updates

Feb 2, 21 Brookline Capital
Buy
Aug 24, 20 Ladenburg Thalmann
Buy
Dec 4, 19 Benchmark
Speculative Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for CNS Pharmaceuticals?
  • Does CNS Pharmaceuticals pay dividends?
  • What sector is CNS Pharmaceuticals in?
  • What industry is CNS Pharmaceuticals in?
  • What country is CNS Pharmaceuticals based in?
  • When did CNS Pharmaceuticals go public?
  • Is CNS Pharmaceuticals in the S&P 500?
  • Is CNS Pharmaceuticals in the NASDAQ 100?
  • Is CNS Pharmaceuticals in the Dow Jones?
  • When was CNS Pharmaceuticals's last earnings report?
  • When does CNS Pharmaceuticals report earnings?
  • Should I buy CNS Pharmaceuticals stock now?

What is the ticker symbol for CNS Pharmaceuticals?

The ticker symbol for CNS Pharmaceuticals is NASDAQ:CNSP

Does CNS Pharmaceuticals pay dividends?

No, CNS Pharmaceuticals does not pay dividends

What sector is CNS Pharmaceuticals in?

CNS Pharmaceuticals is in the Healthcare sector

What industry is CNS Pharmaceuticals in?

CNS Pharmaceuticals is in the Biotechnology industry

What country is CNS Pharmaceuticals based in?

CNS Pharmaceuticals is headquartered in United States

When did CNS Pharmaceuticals go public?

CNS Pharmaceuticals's initial public offering (IPO) was on November 8, 2019

Is CNS Pharmaceuticals in the S&P 500?

No, CNS Pharmaceuticals is not included in the S&P 500 index

Is CNS Pharmaceuticals in the NASDAQ 100?

No, CNS Pharmaceuticals is not included in the NASDAQ 100 index

Is CNS Pharmaceuticals in the Dow Jones?

No, CNS Pharmaceuticals is not included in the Dow Jones index

When was CNS Pharmaceuticals's last earnings report?

CNS Pharmaceuticals's most recent earnings report was on Nov 14, 2024

When does CNS Pharmaceuticals report earnings?

The next expected earnings date for CNS Pharmaceuticals is Apr 1, 2025

Should I buy CNS Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions